Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Prestige Consumer Healthcare Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 312 | 4 | 305 | −3 |
| Shares | 51.3M | 231.1K | 51.0M | −52.3K (−0.1%) |
| Value | $3.72B | $16.7M | $3.51B | −$192.6M (−5.2%) |
4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (36)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (4)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Ziegler Capital Management, LLC | 162,381 | $11.8M |
| Credit Suisse AG | 57,435 | $4.17M |
| Shell Asset Management Co | 6,379 | $439.0K |
| KLR Investment Advisors, LLC | 4,908 | $342.6K |